Nanoformulation of Olaparib Amplifies PARP Inhibition and Sensitizes PTEN/TP53- Deficient Prostate Cancer to Radiation

Molecular Cancer Therapeutics
Anne L van de VenSrinivas Sridhar

Abstract

The use of PARP inhibitors in combination with radiotherapy is a promising strategy to locally enhance DNA damage in tumors. Here we show that radiation-resistant cells and tumors derived from a Pten/Trp53-deficient mouse model of advanced prostate cancer are rendered radiation sensitive following treatment with NanoOlaparib, a lipid-based injectable nanoformulation of olaparib. This enhancement in radiosensitivity is accompanied by radiation dose-dependent changes in γ-H2AX expression and is specific to NanoOlaparib alone. In animals, twice-weekly intravenous administration of NanoOlaparib results in significant tumor growth inhibition, whereas previous studies of oral olaparib as monotherapy have shown no therapeutic efficacy. When NanoOlaparib is administered prior to radiation, a single dose of radiation is sufficient to triple the median mouse survival time compared to radiation only controls. Half of mice treated with NanoOlaparib + radiation achieved a complete response over the 13-week study duration. Using ferumoxytol as a surrogate nanoparticle, MRI studies revealed that NanoOlaparib enhances the intratumoral accumulation of systemically administered nanoparticles. NanoOlaparib-treated tumors showed up to 19-fold high...Continue Reading

References

Dec 24, 2003·PLoS Biology·Lloyd C TrotmanPier Paolo Pandolfi
Jan 8, 2004·Journal of the National Cancer Institute·Christopher R CalabreseNicola J Curtin
Jan 30, 2007·Nature Clinical Practice. Oncology·Tanguy Y SeiwertEverett E Vokes
Apr 5, 2007·Nature Protocols·Nicolaas A P FrankenChris van Bree
Jan 17, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrea L RussoKevin Camphausen
Sep 29, 2009·The Journal of Biological Chemistry·Otto S GildemeisterKendall L Knight
Dec 17, 2009·Histopathology·Anita MitraChristopher S Foster
Apr 2, 2011·International Journal of Ayurveda Research·Manish Kumar GoelJugal Kishore
Oct 6, 2011·Molecular Cancer Therapeutics·Joana M SenraIan J Stratford
Nov 25, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael FraserRobert G Bristow
Jul 10, 2012·Magnetic Resonance Imaging·Andriy FedorovRon Kikinis
Oct 6, 2012·Advanced Drug Delivery Reviews·Theresa M Allen, Pieter R Cullis
Nov 3, 2012·Cancer Research·Junko MuraiYves Pommier
Nov 15, 2012·Radiation Research·Ross I BerbecoG Mike Makrigiorgos
Feb 19, 2013·Mutation Research·Vanessa ValdiglesiasStefano Bonassi
May 3, 2013·Nature·Cyriac KandothDouglas A Levine
Jul 25, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yuqiao ShenAlan Ashworth
Nov 10, 2013·Neoplasia : an International Journal for Oncology Research·Sumin HanFelix Y Feng
May 16, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BalmañaJ E Garber
May 29, 2014·Cancer Discovery·Enrique González-BillalabeitiaPier Paolo Pandolfi
Aug 30, 2014·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·Codi Amir GharagouzlooSrinivas Sridhar
Nov 5, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bella KaufmanSusan M Domchek
Feb 3, 2015·Nature Structural & Molecular Biology·Tatiana KentRichard T Pomerantz
May 20, 2015·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Caroline V M VerhagenConchita Vens
Oct 29, 2015·The New England Journal of Medicine·Joaquin MateoJohann S de Bono
Nov 17, 2015·International Journal of Molecular Sciences·Byeong Mo KimYonggeun Hong
Nov 20, 2015·Science Translational Medicine·Miles A MillerRalph Weissleder
Apr 2, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Raquibul HannanRobert Timmerman
Feb 6, 2017·Methods in Molecular Biology·Autumn D ParoAnne L van de Ven

❮ Previous
Next ❯

Citations

Feb 21, 2018·Nature Reviews. Urology·Tamara JamaspishviliTamara L Lotan
Feb 27, 2018·Cancer Medicine·Yize MaoShengping Li
Jun 2, 2020·American Society of Clinical Oncology Educational Book·Benedito A CarneiroRahul Aggarwal
Dec 26, 2018·Journal of Cellular Biochemistry·Yuemei YangWeiliang Ye
Feb 1, 2021·Cancer Letters·Ignacio Campillo-MarcosPedro A Lazo
Dec 18, 2020·Frontiers in Chemistry·Bijay SinghSrinivas Sridhar
Jun 10, 2021·Clinical Epigenetics·Catarina Macedo-SilvaLucia Altucci
Oct 19, 2021·Frontiers in Neurology·Joshua LeastonCraig F Ferris

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.